(Q42383499)

28 October 2017

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease (English)

1 reference

28 October 2017

Rajaram N

1

1 reference

28 October 2017

Tatake RJ

series ordinal

2

1 reference

28 October 2017

Advani SH

series ordinal

3

1 reference

28 October 2017

Gangal SG

series ordinal

4

1 reference

28 October 2017

language of work or name

English

0 references

publication date

1 August 1990

1 reference

British Journal of Cancer

28 October 2017

1 reference

28 October 2017

62

1 reference

28 October 2017

2

1 reference

28 October 2017

205-208

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.261

28 October 2017

0 references

cites work

Low natural killer cell activity in patients with malignant lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Natural killer cell activity during the course of disease in patients with Hodgkin's disease.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Effector immune mechanisms in cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Hodgkin disease: malignancy, inflammation and abnormal immunity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

The immune derangement in Hodgkin's disease.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Natural killer and lymphokine-activated killer cell functions in chronic myeloid leukemia

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971824

Evaluation of carcinoembryonic antigen levels in gastric juice, stomach mucosa and plasma in high-risk and gastric cancer patients

28 May 2018

1 reference

12 December 2020

Natural and antibody-dependent cellular cytotoxicity in chronic myeloid leukemia patients in remission

1 reference

12 December 2020

Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Effect of exogenous interleukins on in vitro responses of T lymphocytes from patients with Hodgkin disease

1 reference

12 December 2020

A killing defect of natural killer cells with the absence of natural killer cytotoxic factors in a child with Hodgkin's disease

1 reference

12 December 2020

Production of interleukin-2 and expression of tac antigen in Hodgkin disease

1 reference

12 December 2020

Demonstration of inhibitory factors affecting cell-mediated immunity in patients with Hodgkin's disease

1 reference

12 December 2020

Suppressive effect of adherent mononuclear cells from peripheral blood of patients with Hodgkin's disease on PHA responsiveness

1 reference

12 December 2020

Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment

1 reference

12 December 2020

Depressed spontaneous natural killing and interferon augmentation in patients with malignant lymphoma

1 reference

12 December 2020

In vitro radiosensitivity of the spontaneous cytotoxicity of blood lymphocytes in patients with untreated Hodgkin's disease

1 reference

12 December 2020

Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential

1 reference

12 December 2020

Depressed NK cell activity of peripheral blood mononuclear cells in untreated Hodgkin's disease: Enhancing effect of interferon in vitro

1 reference

12 December 2020

Large granular lymphocytes, Leu 7 reactivity and natural killer cell function in peripheral blood of patients with Hodgkin's disease

1 reference

12 December 2020

Lymphokine activated killing of fresh human leukaemias

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.261

1 reference

28 October 2017

1 reference

28 October 2017

1 reference